According to Revive Therapeutics latest financial reports the cash on hand of RVVTF is $1.53M, an decrease of -46.69% to 2022. At the end of 2022 company had $2.88M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $1.53M | -46.69% |
2022 | $2.88M | -76.41% |
2021 | $12.19M | 1020.48% |
2020 | $1.09M | 211.74% |
2019 | $349.06K | - |